» Articles » PMID: 36087384

Circular RNA 0010117 Promotes Aggressive Glioblastoma Behavior by Regulating the MiRNA-6779-5p/SPEN Axis

Overview
Journal Transl Oncol
Specialty Oncology
Date 2022 Sep 10
PMID 36087384
Authors
Affiliations
Soon will be listed here.
Abstract

Noncoding RNAs (ncRNAs) play important roles in cancer biology, providing potential targets for cancer intervention. As a new class of endogenous noncoding RNAs, circular RNAs (circRNAs) have been recently identified in cell development and function, and certain types of pathological responses contribute to cancer progression, including glioblastoma. However, the potential mechanisms underlying the relationship between circRNAs and glioblastoma progression are still largely unknown. Methods: The expression and roles of circular RNA 0010117 (circ-0010117) were examined in vitro and in vivo. Quantitative RT‒PCR and western blotting were used to measure the expression of circRNA, miRNA, each gene, or related proteins. Cell biology experiments were performed to detect the biological function of circ-0010117 in glioblastoma cell lines. Moreover, bioinformatics analysis, luciferase reporter assays, and functional complementation analysis were carried out to investigate the target genes. Tumorigenesis was also evaluated by xenografting cells into nude mice. In this study, we found that circ-0010117 is downregulated in glioblastoma compared with corresponding paratumoural tissues. Subsequently, we observed that circ-0010117 can regulate aggressiveness in glioblastoma cells through miR-6779-5p. Furthermore, SPEN was verified as a direct target of miR-6779-5p and contributes to the circ-0010117 regulatory network. In addition, we identified that overexpression of circ-0010117 can suppress tumorigenesis in nude mice. Our findings indicate that circular RNA 0010117 promotes the aggressive behavior of glioblastoma by regulating the miRNA-6779-5p/SPEN axis. Our results provide a rationale for the use of circ-0010117 as a novel potential therapeutic target in glioblastoma.

Citing Articles

The Role of the Dysregulation of circRNAs Expression in Glioblastoma Multiforme.

Wang Y, Yu Y, Yu J, Wang C, Wang Y, Fu R J Mol Neurosci. 2025; 75(1):9.

PMID: 39841303 DOI: 10.1007/s12031-024-02285-5.


circSORBS1 inhibits lung cancer progression by sponging miR-6779-5p and directly binding RUFY3 mRNA.

Xu H, Zheng Y, Wu J, Zhang R, Zhao Q, Chen S J Transl Med. 2024; 22(1):590.

PMID: 38915053 PMC: 11197270. DOI: 10.1186/s12967-024-05423-0.


The Glioblastoma CircularRNAome.

Tirpe A, Streianu C, Tirpe S, Kocijancic A, Pirlog R, Pirlog B Int J Mol Sci. 2023; 24(19).

PMID: 37833993 PMC: 10572686. DOI: 10.3390/ijms241914545.


Underlying mechanisms and clinical potential of circRNAs in glioblastoma.

Zhang L, Zhang Y, Gao H, Li X, Li P Oncol Res. 2023; 31(4):449-462.

PMID: 37415736 PMC: 10319586. DOI: 10.32604/or.2023.029062.


SPOC domain proteins in health and disease.

Appel L, Benedum J, Engl M, Platzer S, Schleiffer A, Strobl X Genes Dev. 2023; 37(5-6):140-170.

PMID: 36927757 PMC: 10111866. DOI: 10.1101/gad.350314.122.


References
1.
Zhang X, Zhong B, Zhang W, Wu J, Wang Y . Circular RNA CircMTO1 Inhibits Proliferation of Glioblastoma Cells via miR-92/WWOX Signaling Pathway. Med Sci Monit. 2019; 25:6454-6461. PMC: 6738003. DOI: 10.12659/MSM.918676. View

2.
Omuro A, DeAngelis L . Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013; 310(17):1842-50. DOI: 10.1001/jama.2013.280319. View

3.
Wang M, Yu F, Wu W, Zhang Y, Chang W, Ponnusamy M . Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci. 2017; 13(12):1497-1506. PMC: 5723916. DOI: 10.7150/ijbs.22531. View

4.
Chang X, Zhu G, Cai Z, Wang Y, Lian R, Tang X . miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy. Front Endocrinol (Lausanne). 2021; 12:771552. PMC: 8631471. DOI: 10.3389/fendo.2021.771552. View

5.
Zhu F, Cheng C, Qin H, Wang H, Yu H . A novel circular RNA circENTPD7 contributes to glioblastoma progression by targeting ROS1. Cancer Cell Int. 2020; 20:118. PMC: 7147020. DOI: 10.1186/s12935-020-01208-9. View